+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
Cell Therapy Market 2024-2028 - Product Thumbnail Image

Cell Therapy Market 2024-2028

  • Report
  • August 2024
  • 166 Pages
  • Global
From
From
From
Alcoholic Hepatitis Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Alcoholic Hepatitis Treatment Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 170 Pages
  • Global
From
Rheumatoid Arthritis Drugs Market Report 2025 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Primary Sclerosing Cholangitis - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Sclerosing Cholangitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Esophageal Cancer Market Report 2025 - Product Thumbnail Image

Esophageal Cancer Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Synthetic Biology: Global Markets - Product Thumbnail Image

Synthetic Biology: Global Markets

  • Report
  • August 2024
  • 137 Pages
  • Global
From
From
CAR T-cell Therapy Market 2025-2029 - Product Thumbnail Image

CAR T-cell Therapy Market 2025-2029

  • Report
  • January 2025
  • 199 Pages
  • Global
From
Loading Indicator